AVNT AVIENT CORP
Q3 2025 10-Q
Filed: Nov 5, 2025Period ending Sep 30, 2025
Health Care
Plastic Materials, Synth Resins & Nonvulcan ElastomersSEC EDGAR AVIENT CORP (AVNT) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Nov 5, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Risk Factors
- • Newly added risk: Increased foreign trade policy risks triggered by U.S. tariffs and retaliatory actions by other countries impacting global demand
- • Most materially updated risk: Tariffs and trade barriers from U.S. policy changes heightening restrictions and economic disincentives on international trade
Quarterly Financial SummaryXBRL
Revenue
$807M
Net Income
$33M
Gross Margin
30.4%
Operating Margin
8.3%
Net Margin
4.0%
ROE
1.4%
Total Assets
$6.1B
Source: XBRL data from AVIENT CORP Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on AVIENT CORP
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.